Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestMortgage LoansNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - DoubtfulReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

WORK Medical Technology (WOK) Receivables (2023 - 2025)

WORK Medical Technology (WOK) posted Receivables of $2.2 million for Q3 2025, down 4.07% on a QoQ basis from $2.3 million in Q1 2025, and down 29.17% year-over-year from $3.1 million in Q3 2024.

WORK Medical Technology (WOK) has 3 years of Receivables data on file, last reported at $2.2 million in Q3 2025.

  • In Q3 2025, Receivables fell 29.17% year-over-year to $2.2 million; the TTM figure through Sep 2025 stood at $2.2 million (down 29.17% YoY), while the FY2025 annual figure was $2.2 million, down 29.17% from the prior year.
  • Receivables declined to $2.2 million in Q3 2025, from $2.3 million in the prior quarter.
  • Across five years, Receivables topped out at $8.6 million in Q3 2023 and bottomed at $2.2 million in Q3 2025.
  • A 3-year average of $4.0 million and a median of $2.7 million in 2024 frame the typical range for Receivables.
  • Annual changes were most pronounced in 2024 — Receivables sank 64.43% — and 2025, when it decreased 29.17%.
  • Year by year, Receivables stood at $8.6 million in 2023, then sank by 64.43% to $3.1 million in 2024, then declined by 29.17% to $2.2 million in 2025.
  • The last three Receivables figures came in at $2.2 million (Q3 2025), $2.3 million (Q1 2025), and $3.1 million (Q3 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Receivables (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 8.21 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 3.57 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 6.36 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 3.15 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 973.00 Mn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 3.82 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 1.11 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 4.50 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 1.09 Bn
10 WORK Medical Technology - - - 2.16 Mn

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 2.16 Mn
Mar 31, 2025 2.25 Mn
Sep 30, 2024 2.05 Mn
Sep 30, 2023 7.57 Mn